{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T13:40:19Z","timestamp":1682948419124},"reference-count":32,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Murine hybridoma monoclonal antibodies (MAbs) were produced against the capsular antigens of serogroups B, C, Y, and W135 meningococci. Each serogroup-specific MAb reacted with the extracted capsular polysaccharide from its homologous serogroup only and did not react with capsules from the other three serogroups. The application of these MAbs for serogroup identification of meningococci was demonstrated by their abilities to correctly identify 183 clinical isolates of 185 meningococci recovered from individual invasive meningococcal disease (IMD) patients during routine surveillance in 2002. The remaining two meningococci were identified by PCR grouping as C in one case and Y in another, but neither isolate was positive by bacterial agglutination using rabbit antisera or by enzyme-linked immunosorbent assay using MAbs. The specificities of the anti-Y and anti-W135 MAbs were further assessed by tests with 37 serogroup W135 and 106 serogroup Y meningococci recovered from IMD cases during 1999 to 2001 and 2003. All 143 meningococci except one serogroup Y isolate were correctly identified by positive reactions with the corresponding MAbs that identified their homologous serogroups. The single serogroup Y isolate was received as nonagglutinable and tested as negative with both rabbit anti-Y antiserum and anti-Y MAb but was positive for the serogroup Y-specific<jats:italic>siaD<\/jats:italic>gene. The advantage of using MAbs for serogrouping of meningococci is discussed.<\/jats:p>","DOI":"10.1128\/cdli.12.1.152-156.2005","type":"journal-article","created":{"date-parts":[[2005,1,10]],"date-time":"2005-01-10T23:08:03Z","timestamp":1105398483000},"page":"152-156","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["Serological Specificities of Murine Hybridoma Monoclonal Antibodies against<i>Neisseria meningitidis<\/i>Serogroups B, C, Y, and W135 and Evaluation of Their Usefulness as Serogrouping Reagents by Indirect Whole-Cell Enzyme-Linked Immunosorbent Assay"],"prefix":"10.1128","volume":"12","author":[{"given":"Raymond S. W.","family":"Tsang","sequence":"first","affiliation":[{"name":"Laboratory for Pathogenic Neisseria and Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Health Canada, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendell D.","family":"Zollinger","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research, Washington, D.C."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1574-6968.1987.tb02626.x","volume":"48","year":"1987","unstructured":"Abdillahi, H., and J. T. Poolman. 1987. Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett.48:367-371.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1139\/m79-113","volume":"25","year":"1979","unstructured":"Ashton, F. E., A. Ryan, B. B. Diena, and C. E. Frasch. 1979. Evaluation of the antiserum agar method for the serogroup identification of Neisseria meningitidis. Can. J. Microbiol.25:784-787.","journal-title":"Can. J. Microbiol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1139\/m80-109","volume":"26","year":"1980","unstructured":"Ashton, F. E., A. Ryan, and B. B. Diena. 1980. Improved antiserum agar method for the serogroup differentiation of Neisseria meningitidis Y and W135. Can. J. Microbiol.26:630-632.","journal-title":"Can. J. Microbiol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.4.1764-1765.2004"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02935517","volume":"6","year":"1987","unstructured":"Bitter-Suermann, D., and J. Roth. 1987. Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic bacteria, differentiating cells and tumor cells. Immunol. Res.6:225-237.","journal-title":"Immunol. Res."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S0950268896007261","volume":"118","year":"1997","unstructured":"Borrow, R., H. Claus, M. Guiver, L. Smart, D. M. Jones, E. B. Kaczmarski, M. Frosch, and A. J. Fox. 1997. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialytransferase (siaD) PCR ELISA. Epidemiol. Infect.118:111-117.","journal-title":"Epidemiol. Infect."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1574-6968.1998.tb12862.x","volume":"159","year":"1998","unstructured":"Borrow, R., H. Claus, U. Chaudhry, M. Guiver, K. B. Kaczmarksi, M. Frosch, and A. J. Fox. 1998. SiaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal disease. FEMS Microbiol. Lett.159:209-214.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1099\/00221287-148-6-1813","volume":"148","year":"2002","unstructured":"Claus, H., M. C. J. Maiden, R. Maag, M. Frosch, and U. Vogel. 2002. Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology148:1813-1819.","journal-title":"Microbiology"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.7.5.410-414.1978"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.9.4.547-548.1979"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.4.1766-1768.2003"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0022-3476(81)80250-8","volume":"99","year":"1981","unstructured":"Edwards, M. S., and C. J. Baker. 1981. Complications and sequelae of meningococcal infections in children. J. Pediatr.99:540-545.","journal-title":"J. Pediatr."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/hyb.1992.11.677","volume":"11","year":"1992","unstructured":"Hurpin, C. M., E. D. Carosella, and P. A. Cazenave. 1992. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide. Hybridoma11:677-687.","journal-title":"Hybridoma"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00006454-199611000-00009","volume":"15","year":"1996","unstructured":"Kirsch, E. A., R. P. Barton, L. Kitchen, and B. P. Giroir. 1996. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr. Infect. Dis. J.15:967-978.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","year":"1975","unstructured":"Kohler, G., and C. Milstein. 1975. Continuous culture of fused cells secreting antibody of predefined specificity. Nature (London)256:495-497.","journal-title":"Nature (London)"},{"key":"e_1_3_2_17_2","first-page":"131","volume":"67","year":"2001","unstructured":"Kuipers, B., G. van den Dobbelsteen, E. Wedege, and L. Van Alphen. 2001. Serological characterization. Methods Mol. Med.67:131-145.","journal-title":"Methods Mol. Med."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.6.2697-2699.2003"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.129.5.2172","volume":"129","year":"1982","unstructured":"Mandrell, R. E., and W. D. Zollinger. 1982. Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. J. Immunol.129:2172-2178.","journal-title":"J. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.1.320-328.2004"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0959-440X(98)80144-9","volume":"8","year":"1998","unstructured":"Muhlenhoff, M., M. Eckhardt, and R. Gerardy-Schahn. 1998. Polysialic acid: three dimensional structure, biosynthesis and function. Curr. Opin. Struct. Biol.8:558-564.","journal-title":"Curr. Opin. Struct. Biol."},{"key":"e_1_3_2_22_2","first-page":"927","year":"2001","unstructured":"Munford, R. S. 2001. Meningococcal infections: disease caused by gram-negative bacteria, p. 927-931. In E. Braunwald, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, and J. L. Jameson (ed.), Harrison's principles of internal medicine, 15th ed. McGraw-Hill Medical Publishing Division, New York, N.Y.","journal-title":"Harrison's principles of internal medicine"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.7.1447-1452.1991"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.27.1.74-77.1989"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/clinids\/5.1.71","volume":"5","year":"1983","unstructured":"Peltola, H. 1983. Meningococcal disease: still with us. Rev. Infect. Dis.5:71-91.","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.11.4325-4328.2002"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","volume":"180","year":"1999","unstructured":"Rosenstein, N. E., B. A. Perkins, D. S. Stephens, L. Lefkowitz, M. L. Cartter, R. Danila, P. Cieslak, K. A. Shutt, T. Popovic, A. Schuchat, L. H. Harrison, A. L. Reingold, et al. 1999. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis.180:1894-1901.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","volume":"344","year":"2001","unstructured":"Rosenstein, N. E., B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes. 2001. Meningococcal disease. N. Engl. J. Med.344:1378-1388.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_29_2","first-page":"391","volume":"13","year":"2002","unstructured":"Tsang, R. S. W., S. G. Squires, W. D. Zollinger, and F. E. Ashton. 2002. Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001. Can. J. Infect. Dis.13:391-396.","journal-title":"Can. J. Infect. Dis."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.12.3326-3327.1995"},{"key":"e_1_3_2_31_2","first-page":"33","year":"1987","unstructured":"Vedros, N. A. 1987. Development of meningococcal serogroups, p. 33-37. In N. A. Vedros (ed.), Evolution of meningococcal disease,vol. II. CRC Press, Boca Raton, Fla.","journal-title":"Evolution of meningococcal disease"},{"key":"e_1_3_2_32_2","first-page":"187","volume":"67","year":"2001","unstructured":"Vogel, U., H. Claus, and M. Frosch. 2001. Capsular operons. Methods Mol. Med.67:187-201.","journal-title":"Methods Mol. Med."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.7.5.470-473.1978"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.12.1.152-156.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.12.1.152-156.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T13:26:32Z","timestamp":1682947592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.12.1.152-156.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1128\/CDLI.12.1.152-156.2005"],"URL":"https:\/\/doi.org\/10.1128\/cdli.12.1.152-156.2005","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"2004-07-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}